首頁 > 市場調查報告書 > 製藥

臨床實驗

市場調查報告書

商品編碼

1121483

全球臨床試驗支持服務市場預測（2022-2030）

Global Clinical Trials Support Services Market Forecast 2022-2030

出版日期: 2022年09月01日 | 出版商:

Inkwood Research | 英文 230 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

從 2022 年到 2030 年（評估期），全球臨床試驗支持服務市場預計將以 7.65% 的複合年增長率增長。市場增長因素包括慢性病和病毒爆發的流行率上升以及臨床試驗支持服務的各種好處。

按地區劃分，由於該地區有幾家行業主要參與者和先進的臨床研究，預計到 2030 年北美市場將佔據約 38.27% 的市場份額。

本報告審查了全球臨床試驗支持服務市場，並提供了市場規模和預測、市場動態、按細分市場/地區劃分的市場分析、競爭格局和主要參與者概況等信息。

內容

第一章研究範圍與研究方法

調查目的
調查範圍
調查方法
先決條件和限制

第 2 章執行摘要

市場規模和估計
市場概覽

第三章市場動態

主要驅動力
- 慢性病和病毒的發病率不斷上升
- 臨床試驗支持服務的好處
主要製約因素
- 開源/免費軟件的可用性
- 嚴格的規定

第四章關鍵分析

COVID-19 對臨床試驗支持服務的影響
主要市場趨勢
波特五力分析
機會矩陣
供應商情況
價值鏈分析
主要購買標準
監管框架

第 5 章市場分階段

第一階段
第二階段
第三階段
第四階段

第 6 章贊助商市場

製藥和生物製藥公司
醫療器械公司
其他

第 7 章按服務劃分的市場

臨床試驗設施的管理
管理人員
患者招募管理
- 患者招募和掛號服務
- 留住病人
- 其他
IRB
數據管理
其他服務

第八章區域分析

北美
- 市場規模和估計
- 主要增長因素
- 主要問題
- 主要公司
- 國家/地區分析
歐洲
- 市場規模和估計
- 主要增長因素
- 主要問題
- 主要公司
- 國家/地區分析
亞太地區
- 市場規模和估計
- 主要增長因素
- 主要問題
- 主要公司
- 國家/地區分析
世界其他地區
- 市場規模和估計
- 主要增長因素
- 主要問題
- 主要公司
- 國家/地區分析

第 9 章競爭格局

重大戰略發展
- 併購
- 產品發布和開發
- 合作夥伴關係和合同
- 業務擴展和銷售
公司簡介
- ADVANCED CLINICAL
- ALCURA
- CHARLES RIVER LABORATORIES INC
- CLINIPACE
- CTI CLINICAL TRIAL AND CONSULTING SERVICES INC
- ICON PLC
- IQVIA
- KCR
- LABCORP DRUG DEVELOPMENT
- MEDPACE
- PAREXEL
- PSI CRO
- SYNEOS HEALTH
- WORLDWIDE CLINICAL TRIALS
- WUXI APPTEC

簡介目錄圖表

Product Code: 47763

KEY FINDINGS

The global clinical trials support services market is estimated to boost with a 7.65% CAGR during the assessment period, 2022-2030. The market growth is driven by the rising prevalence of chronic disease & virus outbreaks and various benefits of clinical trial support services.

MARKET INSIGHTS

Clinical trials are controlled studies on humans to ensure the efficacy of drugs, food, and other product. These clinical trials are designed to satisfy the requirements of an agency related to product approvals and other human studies used in developing a product. Experiments and tests are performed on people and animals, and later the researchers or the investigators examine the outcomes

Further, support services make the clinical trial process easier. There are various key drivers for the growth of the studied market: the rise in the number of diseases and overcoming the challenges in clinical trials. The rising health problems and diseases have increased the clinical trials of new vaccines for new viruses and new and efficient drugs for the existing problems.

REGIONAL INSIGHTS

The global clinical trials support services market growth evaluation includes a thorough analysis of Europe, North America, Asia-Pacific, and Rest of World. North America is expected to capture around 38.27% market share by 2030 due to the presence of numerous leading industry players and advanced clinical studies in the region.

COMPETITIVE INSIGHTS

The competition is very high among the companies since the global clinical trials support services market is consolidated. Also, there are entry barriers for new entrants because of the presence of influential market leaders.

Some of the key market players include: ICON PLC, IQVIA, Parexel, PSI CRO, KCR, etc.

Our report offerings include:

Explore key findings of the overall market

Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)

Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions

Market Segmentation caters to a thorough assessment of key segments with their market estimations

Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.

Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.

Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. RISING PREVALENCE OF CHRONIC DISEASE & VIRUS OUTBREAKS
- 3.1.2. BENEFITS OF CLINICAL TRIAL SUPPORT SERVICES
3.2. KEY RESTRAINTS
- 3.2.1. AVAILABILITY OF OPEN-SOURCE/FREEWARE SOFTWARE
- 3.2.2. STRINGENT REGULATIONS

4. KEY ANALYTICS

4.1. IMPACT OF COVID-19 ON CLINICAL TRIALS SUPPORT SERVICES MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER'S FIVE FORCES ANALYSIS
- 4.3.1. BUYERS POWER
- 4.3.2. SUPPLIERS POWER
- 4.3.3. SUBSTITUTION
- 4.3.4. NEW ENTRANTS
- 4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
4.6. VALUE CHAIN ANALYSIS
4.7. KEY BUYING CRITERIA
- 4.7.1. PERFORMANCE
- 4.7.2. EASE OF USE
- 4.7.3. SECURITY
- 4.7.4. COST-EFFECTIVENESS
4.8. REGULATORY FRAMEWORK

5. MARKET BY PHASE

5.1. PHASE I
5.2. PHASE II
5.3. PHASE III
5.4. PHASE IV

6. MARKET BY SPONSOR

6.1. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
6.2. MEDICAL DEVICE COMPANIES
6.3. OTHER SPONSORS

7. MARKET BY SERVICE

7.1. CLINICAL TRIAL SITE MANAGEMENT
7.2. ADMINISTRATIVE STAFF
7.3. PATIENT RECRUITMENT MANAGEMENT
- 7.3.1. PATIENT RECRUITMENT & REGISTRY SERVICES
- 7.3.2. PATIENT RETENTION
- 7.3.3. OTHER PATIENT RECRUITMENT MANAGEMENT
7.4. IRB
7.5. DATA MANAGEMENT
7.6. OTHER SERVICES

8. GEOGRAPHICAL ANALYSIS

8.1. NORTH AMERICA
- 8.1.1. MARKET SIZE & ESTIMATES
- 8.1.2. KEY GROWTH ENABLERS
- 8.1.3. KEY CHALLENGES
- 8.1.4. KEY PLAYERS
- 8.1.5. COUNTRY ANALYSIS
  - 8.1.5.1. UNITED STATES
  - 8.1.5.2. CANADA
8.2. EUROPE
- 8.2.1. MARKET SIZE & ESTIMATES
- 8.2.2. KEY GROWTH ENABLERS
- 8.2.3. KEY CHALLENGES
- 8.2.4. KEY PLAYERS
- 8.2.5. COUNTRY ANALYSIS
  - 8.2.5.1. UNITED KINGDOM
  - 8.2.5.2. GERMANY
  - 8.2.5.3. FRANCE
  - 8.2.5.4. SPAIN
  - 8.2.5.5. ITALY
  - 8.2.5.6. SWEDEN
  - 8.2.5.7. DENMARK
  - 8.2.5.8. HUNGARY
  - 8.2.5.9. REST OF EUROPE
8.3. ASIA-PACIFIC
- 8.3.1. MARKET SIZE & ESTIMATES
- 8.3.2. KEY GROWTH ENABLERS
- 8.3.3. KEY CHALLENGES
- 8.3.4. KEY PLAYERS
- 8.3.5. COUNTRY ANALYSIS
  - 8.3.5.1. CHINA
  - 8.3.5.2. JAPAN
  - 8.3.5.3. INDIA
  - 8.3.5.4. SOUTH KOREA
  - 8.3.5.5. TAIWAN
  - 8.3.5.6. SINGAPORE
  - 8.3.5.7. THAILAND
  - 8.3.5.8. AUSTRALIA & NEW ZEALAND
  - 8.3.5.9. REST OF ASIA-PACIFIC
8.4. REST OF WORLD
- 8.4.1. MARKET SIZE & ESTIMATES
- 8.4.2. KEY GROWTH ENABLERS
- 8.4.3. KEY CHALLENGES
- 8.4.4. KEY PLAYERS
- 8.4.5. COUNTRY ANALYSIS
  - 8.4.5.1. LATIN AMERICA
  - 8.4.5.2. MIDDLE EAST & AFRICA

9. COMPETITIVE LANDSCAPE

9.1. KEY STRATEGIC DEVELOPMENTS
- 9.1.1. MERGERS & ACQUISITIONS
- 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 9.1.3. PARTNERSHIPS & AGREEMENTS
- 9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
- 9.2.1. ADVANCED CLINICAL
- 9.2.2. ALCURA
- 9.2.3. CHARLES RIVER LABORATORIES INC
- 9.2.4. CLINIPACE
- 9.2.5. CTI CLINICAL TRIAL AND CONSULTING SERVICES INC
- 9.2.6. ICON PLC
- 9.2.7. IQVIA
- 9.2.8. KCR
- 9.2.9. LABCORP DRUG DEVELOPMENT
- 9.2.10. MEDPACE
- 9.2.11. PAREXEL
- 9.2.12. PSI CRO
- 9.2.13. SYNEOS HEALTH
- 9.2.14. WORLDWIDE CLINICAL TRIALS
- 9.2.15. WUXI APPTEC

簡介目錄圖表

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - CLINICAL TRIALS SUPPORT SERVICES
TABLE 2: LIST OF PANDEMIC OUTBREAKS
TABLE 3: LIST OF OPEN-SOURCE SOFTWARE
TABLE 4: LIST OF PARTNERSHIPS
TABLE 5: LAUNCH OF MEDICAL DRUGS
TABLE 6: PROMISING ACQUISITIONS IN THE INDUSTRY
TABLE 7: REGULATORY FRAMEWORK
TABLE 8: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 9: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 10: GLOBAL PHASE I MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 11: GLOBAL PHASE I MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 12: GLOBAL PHASE II MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 13: GLOBAL PHASE II MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 14: GLOBAL PHASE III MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 15: GLOBAL PHASE III MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 16: GLOBAL PHASE IV MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 17: GLOBAL PHASE IV MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 18: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 19: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 20: GLOBAL PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 21: GLOBAL PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 22: GLOBAL MEDICAL DEVICE COMPANIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 23: GLOBAL MEDICAL DEVICE COMPANIES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 24: GLOBAL OTHER SPONSORS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 25: GLOBAL OTHER SPONSORS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 26: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 27: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 28: GLOBAL CLINICAL TRIAL SITE MANAGEMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 29: GLOBAL CLINICAL TRIAL SITE MANAGEMENT MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 30: GLOBAL ADMINISTRATIVE STAFF MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 31: GLOBAL ADMINISTRATIVE STAFF MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 32: GLOBAL PATIENT RECRUITMENT MANAGEMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 33: GLOBAL PATIENT RECRUITMENT MANAGEMENT MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 34: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 35: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 36: GLOBAL PATIENT RECRUITMENT & REGISTRY SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 37: GLOBAL PATIENT RECRUITMENT & REGISTRY SERVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 38: GLOBAL PATIENT RETENTION MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 39: GLOBAL PATIENT RETENTION MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 40: GLOBAL OTHER PATIENT RECRUITMENT MANAGEMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 41: GLOBAL OTHER PATIENT RECRUITMENT MANAGEMENT MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 42: GLOBAL IRB MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 43: GLOBAL IRB MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 44: GLOBAL DATA MANAGEMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 45: GLOBAL DATA MANAGEMENT MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 46: GLOBAL OTHER SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 47: GLOBAL OTHER SERVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 48: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 49: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY GEOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 50: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 51: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 52: LEADING PLAYERS OPERATING IN NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET
TABLE 53: NUMBER AND TYPES OF REGISTERED STUDIES
TABLE 54: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 55: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 56: LEADING PLAYERS OPERATING IN EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET
TABLE 57: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 58: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 59: LEADING PLAYERS OPERATING IN ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET
TABLE 60: REST OF WORLD CLINICAL TRIALS SUPPORT SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 61: REST OF WORLD CLINICAL TRIALS SUPPORT SERVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 62: LEADING PLAYERS OPERATING IN REST OF WORLD CLINICAL TRIALS SUPPORT SERVICES MARKET
TABLE 63: LIST OF MERGERS & ACQUISITIONS
TABLE 64: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 65: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 66: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: VALUE CHAIN ANALYSIS
FIGURE 6: KEY BUYING CRITERIA
FIGURE 7: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY PHASE, IN 2021
FIGURE 8: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE I, 2022-2030 (IN $ MILLION)
FIGURE 9: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE II, 2022-2030 (IN $ MILLION)
FIGURE 10: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE III, 2022-2030 (IN $ MILLION)
FIGURE 11: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE IV, 2022-2030 (IN $ MILLION)
FIGURE 12: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY SPONSOR, IN 2021
FIGURE 13: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, 2022-2030 (IN $ MILLION)
FIGURE 14: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY MEDICAL DEVICE COMPANIES, 2022-2030 (IN $ MILLION)
FIGURE 15: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SPONSORS, 2022-2030 (IN $ MILLION)
FIGURE 16: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY SERVICE, IN 2021
FIGURE 17: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY CLINICAL TRIAL SITE MANAGEMENT, 2022-2030 (IN $ MILLION)
FIGURE 18: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY ADMINISTRATIVE STAFF, 2022-2030 (IN $ MILLION)
FIGURE 19: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, 2022-2030 (IN $ MILLION)
FIGURE 20: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY PATIENT RECRUITMENT MANAGEMENT, IN 2021
FIGURE 21: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT & REGISTRY SERVICES, 2022-2030 (IN $ MILLION)
FIGURE 22: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RETENTION, 2022-2030 (IN $ MILLION)
FIGURE 23: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER PATIENT RECRUITMENT MANAGEMENT, 2022-2030 (IN $ MILLION)
FIGURE 24: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY IRB, 2022-2030 (IN $ MILLION)
FIGURE 25: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY DATA MANAGEMENT, 2022-2030 (IN $ MILLION)
FIGURE 26: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SERVICES, 2022-2030 (IN $ MILLION)
FIGURE 27: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 28: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 29: CANADA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 30: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 31: UNITED KINGDOM CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 32: GERMANY CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 33: FRANCE CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 34: SPAIN CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 35: ITALY CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 36: SWEDEN CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 37: DENMARK CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 38: HUNGARY CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 39: REST OF EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 40: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 41: CHINA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 42: JAPAN CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 43: INDIA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 44: SOUTH KOREA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 45: TAIWAN CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 46: SINGAPORE CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 47: THAILAND CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 48: AUSTRALIA & NEW ZEALAND CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 49: REST OF ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 50: REST OF WORLD CLINICAL TRIALS SUPPORT SERVICES MARKET, REGIONAL OUTLOOK, 2021 & 2030 (IN %)
FIGURE 51: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 52: MIDDLE EAST & AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)